Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth.
about
Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting.Glucocorticoid Signaling in Health and Disease: Insights From Tissue-Specific GR Knockout Mice.Measuring glucocorticoid receptor expression in vivo with PET.
P2860
Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Selective Glucocorticoid Recep ...... istant Prostate Cancer Growth.
@en
type
label
Selective Glucocorticoid Recep ...... istant Prostate Cancer Growth.
@en
prefLabel
Selective Glucocorticoid Recep ...... istant Prostate Cancer Growth.
@en
P2093
P2860
P1476
Selective Glucocorticoid Recep ...... sistant Prostate Cancer Growth
@en
P2093
Calvin VanOpstall
Diana C West
Donald Vander Griend
Jacob Kach
Larischa de Wet
Marc Gillard
Maria A Bacalao
Phillip Selman
Ricardo R Lastra
Russell Z Szmulewitz
P2860
P304
P356
10.1158/1535-7163.MCT-16-0923
P577
2017-04-20T00:00:00Z